MedTech Trailblazers

Andrew Cleeland, CEO of Fogarty Innovation, welcomes back world-renowned cardiologist Dr. Marty Leon, a visionary leader who has shaped the worldwide practice of interventional medicine.

Dr. Leon is professor of medicine at Columbia University Irving Medical Center (CUIMC), Director of Columbia Interventional Cardiovascular Care and of the Cardiac Catheterization Laboratories, founder and Chairman Emeritus of the Cardiovascular Research Foundation, and the driving force behind the Transcatheter Cardiovascular Therapeutics (TCT) conference.

In this episode, Dr. Leon shares further insight into the later stages of his career and future aspirations.

There is virtually no aspect of the cardiovascular health ecosystem that hasn't been impacted by the work of Dr. Marty Leon, professor of medicine at Columbia University Irving Medical Center (CUIMC) and a legendary interventional cardiologist whose many roles and accomplishments have had an indelible effect on the practice of cardiology and the medtech industry.

Dr. Leon's dedication is reflected by the many hats he wears, including Director of Columbia Interventional Cardiovascular Care and Director of the Cardiac Catheterization Laboratories. He is also the founder of the Cardiovascular Research Foundation and the Transcatheter Cardiovascular Therapeutics (TCT) conference.

In this episode, Fogarty Innovation CEO Andrew Cleeland had the pleasure of chatting with Dr. Leon to learn more about the factors that shaped his life and career.

While he needs no introduction, it's always an honor to list Dr. Tom Fogarty's many accomplishments over his nearly eight-decade career as one of the medical device industry's most prolific inventors. Dr. Fogarty has had a profound and lasting impact on patients, on healthcare, on innovation on our industry and many of its leaders.

As an internationally-recognized cardiovascular surgeon, inventor, entrepreneur and vintner, he has dedicated his entire career to improving patient care and is named on over 200 medical device patents, including the "industry standard" Fogarty balloon catheter, which nearly 60 years later is still being used to save the lives and limbs of more than 16 million patients.

Andrew Cleeland had the pleasure of sitting down with his mentor, Dr. Fogarty, to explore several themes: resilience and perseverance, a sense of curiosity and the importance of mentoring.

Dubbed as a "walking encyclopedia of medtech experiences, innovations and impact," Hanson Gifford, CEO and managing director of The Foundry, has been directly involved with or founded over 30 companies in the past 40 years.

In this episode, he rejoins Andrew Cleeland, CEO of Fogarty Innovation, as he shares his views on teamwork, investing, digital health and the future of our industry.

Hanson Gifford, CEO and managing partner of The Foundry, is perhaps best known as a co-founder of this iconic Silicon Valley-based incubator that has blazed the path for numerous successful medtech companies, developing cutting-edge treatments that address a broad range of large, unmet clinical needs.

In this episode, he joins Andrew Cleeland as he shares lessons learned from his youth, his earliest jobs and launching The Foundry.

Jan Garfinkle, founder and managing partner of Arboretum Ventures, rejoins Andrew Cleeland as she shares the reasons behind launching the firm and the grit it took to get the company started.

Jan also discusses the pivotal role she played at the National Venture Capital Association (NVCA) to help ensure venture-backed startups could apply for PPP loans during the pandemic, and why the creation of Venture Forward, which promotes diversity in venture funds and portfolio companies, is so important to her.

Jan Garfinkle, founder and managing partner of Arboretum Ventures, has played a key role in multiple foundational companies in the medtech industry. Today, she supports the early-medtech ecosystem at the firm with a mission that is similar to Fogarty Innovation's: driving down the costs of healthcare through innovation.

Arboretum has invested in 60 portfolio companies, which collectively employ 5,000 people and help over 10 million patients, making a remarkable impact on human health and our economy.

Jan joins Andrew Cleeland as she shares insights behind her successful career.

Paul Yock, MD, has had an unparalleled career as an accomplished physician, innovator and educator. In retrospect, Paul is proudest of the Stanford Biodesign program trainees, many of whom have gone on to lead health technology start-up companies, found innovation training programs, become faculty members of major universities, or return to clinical practice with a new understanding of how to evaluate and solve problems in care.

Learn more about Paul and the organization he formed, as he rejoins Andrew Cleeland, CEO of Fogarty Innovation.

"In addition to the vast impact his inventions have had, I believe Paul's multifaceted legacy will be kept by his influence on the innovators of today and generations well into the future." The iconic Paul Yock, MD, joins Andrew Cleeland as he provides a glimpse into his stellar career as an accomplished physician, innovator and educator.

Paul is the Martha Meier Weiland Professor of Medicine, founding co-chair of Stanford's department of bioengineering and founder of the Stanford Byers Center for Biodesign. He is known for his inventions that have improved care for millions of people around the world, including the Rapid Exchange stenting and balloon angioplasty system and the Smart Needle.

Resources: Fogarty Innovation: www.fogartyinnovation.org MedTech Trailblazers podcast: www.medtechtrailblazers.libsyn.com Paul Yock, MD, bio: www.profiles.stanford.edu/paul-yock Stanford Byers Center for Biodesign: www.biodesign.stanford.edu

Josh Makower, MD, rejoins Andrew Cleeland as he shares his experience working at Pfizer, breaking new ground by launching ExploraMed, and coming full circle as co-founder and now director of Stanford Biodesign.